Rockwell Automation Launches PharmaSuite 12.00 to Accelerate Secure, Scalable Deployments
Rockwell Automation (NYSE: ROK) has launched FactoryTalk PharmaSuite 12.00, an enhanced manufacturing execution system (MES) designed for pharmaceutical and biopharmaceutical manufacturing. The new release features cloud-ready capabilities and a modular architecture to address key industry challenges including high costs, slow implementation, and flexibility limitations.
Key features include: cloud-based deployment using Kubernetes and Linux containers, a new setup tool (MICKA) for automated installation, modular design for scalability, built-in monitoring tools, enhanced cybersecurity, and simplified upgrade processes. The system aims to help manufacturers scale operations faster, simplify global rollouts, and reduce validation time and costs while maintaining regulatory compliance.
Rockwell Automation (NYSE: ROK) ha lanciato FactoryTalk PharmaSuite 12.00, un sistema di esecuzione della produzione (MES) potenziato, progettato per la produzione farmaceutica e biofarmaceutica. La nuova versione presenta funzionalità pronte per il cloud e un'architettura modulare per affrontare le principali sfide del settore, tra cui costi elevati, implementazioni lente e limitazioni di flessibilità.
Le caratteristiche principali includono: implementazione basata su cloud tramite Kubernetes e container Linux, un nuovo strumento di configurazione (MICKA) per l'installazione automatizzata, design modulare per la scalabilità, strumenti di monitoraggio integrati, maggiore sicurezza informatica e processi di aggiornamento semplificati. Il sistema è pensato per aiutare i produttori a scalare le operazioni più rapidamente, semplificare le implementazioni globali e ridurre tempi e costi di validazione, mantenendo la conformità normativa.
Rockwell Automation (NYSE: ROK) ha lanzado FactoryTalk PharmaSuite 12.00, un sistema mejorado de ejecución de manufactura (MES) diseñado para la fabricación farmacéutica y biofarmacéutica. La nueva versión cuenta con capacidades preparadas para la nube y una arquitectura modular para abordar los principales desafíos de la industria, incluyendo altos costos, implementaciones lentas y limitaciones de flexibilidad.
Las características clave incluyen: despliegue basado en la nube utilizando Kubernetes y contenedores Linux, una nueva herramienta de configuración (MICKA) para instalación automatizada, diseño modular para escalabilidad, herramientas integradas de monitoreo, ciberseguridad mejorada y procesos de actualización simplificados. El sistema busca ayudar a los fabricantes a escalar operaciones más rápido, simplificar despliegues globales y reducir el tiempo y costo de validación manteniendo el cumplimiento regulatorio.
Rockwell Automation (NYSE: ROK)은 제약 및 바이오제약 제조를 위해 설계된 향상된 제조 실행 시스템(MES)인 FactoryTalk PharmaSuite 12.00을 출시했습니다. 이번 신규 버전은 클라우드 준비 기능과 모듈식 아키텍처를 갖추어 높은 비용, 느린 구현 속도, 유연성 제한 등 주요 산업 과제를 해결합니다.
주요 기능으로는 Kubernetes와 Linux 컨테이너를 활용한 클라우드 기반 배포, 자동 설치를 위한 새로운 설정 도구(MICKA), 확장성을 위한 모듈형 설계, 내장 모니터링 도구, 강화된 사이버 보안, 간소화된 업그레이드 프로세스가 포함됩니다. 이 시스템은 제조업체가 운영을 더 빠르게 확장하고, 글로벌 롤아웃을 단순화하며, 검증 시간과 비용을 줄이면서 규제 준수를 유지하도록 돕는 것을 목표로 합니다.
Rockwell Automation (NYSE : ROK) a lancé FactoryTalk PharmaSuite 12.00, un système d’exécution de fabrication (MES) amélioré, conçu pour la production pharmaceutique et biopharmaceutique. Cette nouvelle version offre des fonctionnalités prêtes pour le cloud et une architecture modulaire pour répondre aux principaux défis de l’industrie, tels que les coûts élevés, la lenteur des déploiements et les limitations de flexibilité.
Les principales caractéristiques incluent : un déploiement cloud utilisant Kubernetes et des conteneurs Linux, un nouvel outil de configuration (MICKA) pour l’installation automatisée, une conception modulaire pour la montée en charge, des outils de surveillance intégrés, une cybersécurité renforcée et des processus de mise à niveau simplifiés. Le système vise à aider les fabricants à accélérer la montée en charge, simplifier les déploiements mondiaux et réduire le temps et les coûts de validation tout en maintenant la conformité réglementaire.
Rockwell Automation (NYSE: ROK) hat FactoryTalk PharmaSuite 12.00 vorgestellt, ein verbessertes Manufacturing Execution System (MES), das für die pharmazeutische und biopharmazeutische Produktion entwickelt wurde. Die neue Version bietet cloud-fähige Funktionen und eine modulare Architektur, um zentrale Herausforderungen der Branche wie hohe Kosten, langsame Implementierungen und eingeschränkte Flexibilität zu bewältigen.
Zu den Hauptmerkmalen gehören: Cloud-basierte Bereitstellung mit Kubernetes und Linux-Containern, ein neues Einrichtungstool (MICKA) für automatisierte Installationen, modulare Gestaltung für Skalierbarkeit, integrierte Überwachungstools, verbesserte Cybersicherheit und vereinfachte Upgrade-Prozesse. Das System soll Herstellern helfen, ihre Abläufe schneller zu skalieren, weltweite Rollouts zu vereinfachen und Validierungszeit sowie -kosten zu reduzieren, während die Einhaltung von Vorschriften gewährleistet bleibt.
- Introduction of cloud-based deployment capabilities using Kubernetes for faster setup and maintenance
- New automated setup tool (MICKA) reduces manual effort in regulated environments
- Enhanced cybersecurity features meeting industry standards
- Modular design enables easier scaling across multiple sites
- None.
Insights
Rockwell's PharmaSuite 12.00 directly addresses industry pain points with cloud-ready capabilities that could strengthen their position in pharma manufacturing technology.
Rockwell Automation's launch of PharmaSuite 12.00 represents a significant enhancement to their manufacturing execution system (MES) portfolio specifically targeting regulated pharmaceutical environments. The timing is strategic, as BioPhorum has identified that current MES solutions are widely perceived as expensive, implementation-heavy, and insufficiently flexible for modern operations.
The most technically significant aspects of this release include the shift to a containerized architecture running in Kubernetes with Linux containers, which fundamentally changes the deployment model. This architecture transformation enables the cloud-ready capabilities that allow pharmaceutical manufacturers to deploy in various environments (cloud, on-premises, or hybrid) without extensive reconfiguration.
The new Modular Installation Configuration Kit Assistant (MICKA) setup tool addresses a critical pain point in regulated environments by automating installation and validation steps. This directly impacts time-to-value by reducing the extensive manual configuration that typically delays MES implementations in pharmaceutical manufacturing.
From an operational perspective, the containerized components effectively decouple the application from the underlying infrastructure, making cross-site standardization more achievable while reducing validation burdens. This modular approach aligns with the industry trend toward more flexible manufacturing capabilities to accommodate smaller, more diverse production batches.
The built-in monitoring capabilities and upgraded cybersecurity features are particularly valuable in the current regulatory landscape where data integrity is paramount under FDA and EMA guidelines. The system's development using certified secure development practices indicates alignment with standards like IEC 62443, which has become increasingly important for pharma manufacturing systems.
Latest MES release helps pharmaceutical and biopharmaceutical manufacturers simplify system management, improve flexibility and speed time-to-value
As the industry seeks to move faster while ensuring compliance, BioPhorum has noted that current MES solutions are often perceived as expensive, slow to implement and lacking flexibility required for modern operations. PharmaSuite 12.00 directly addresses these pain points, providing a simplified, configurable and future-ready platform for regulated life sciences production.
The latest release introduces a modular architecture and new cloud-ready capabilities, providing manufacturers with increased agility to help meet rapidly evolving production demands. It also features enhanced cybersecurity to support the stringent compliance and data integrity standards required in regulated life sciences environments.
"PharmaSuite 12.00 represents a major step forward in helping life sciences manufacturers embrace modular, digital production while maintaining the highest standards of performance, availability, compliance and security," said Martin Petrick, business manager, MES at Rockwell Automation. "With the flexibility to deploy in the cloud, on-premises or in hybrid models, manufacturers can scale operations faster, simplify global rollouts and reduce the time and cost validation."
Key new features in FactoryTalk PharmaSuite 12.00 include:
- Cloud-Based Deployment: Now runs in Kubernetes using Linux containers, making setup and maintenance faster and more reliable
- New Setup Tool (MICKA): Automates installation and validation steps to reduce manual effort in regulated environments
- Modular Design: Containerized components make it easy to scale across sites and standardize system deployments
- Built-in Monitoring: Centralized tools help detect issues early and speed up troubleshooting
- Strong Cybersecurity: Built using certified secure development practices to meet industry standards
- Easier Upgrades: A new upgrade engine helps keep systems current with the latest features and security updates
FactoryTalk PharmaSuite 12.00 builds on more than 15 years of continuous development and industry expertise. With this release, Rockwell continues to provide pharmaceutical and biopharmaceutical manufacturers with a modern, regulatory-compliant MES platform that supports scalable production, rapid deployment and digital transformation goals.
Click here to learn more about FactoryTalk PharmaSuite.
About Rockwell Automation
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/rockwell-automation-launches-pharmasuite-12-00-to-accelerate-secure-scalable-deployments-302453073.html
SOURCE Rockwell Automation, Inc.
FAQ
What are the key features of Rockwell Automation's PharmaSuite 12.00?
How does PharmaSuite 12.00 benefit pharmaceutical manufacturers?
What deployment options does ROK's PharmaSuite 12.00 offer?
How does PharmaSuite 12.00 address cybersecurity concerns?
